Full text is available at the source.
Abstract
Low expression of SMP30 is significantly associated with malignant progression and poor prognosis in tumors.
- SMP30 is a calcium binding protein linked to cellular aging.
- Reduced levels of SMP30 may indicate more aggressive tumor behavior.
- Low SMP30 expression could serve as a potential diagnostic biomarker.
- SMP30 has the potential to be a therapeutic target in cancer treatment.
Simplified